atenolol and kt 5720

atenolol has been researched along with kt 5720 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satake, N; Shibata, M; Shibata, S1
El-Zohairy, SN; Ezeamuzie, CI; Oriowo, MA1

Other Studies

2 other study(ies) available for atenolol and kt 5720

ArticleYear
The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings.
    British journal of pharmacology, 1996, Volume: 119, Issue:3

    Topics: 4-Aminopyridine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Aorta, Thoracic; Atenolol; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Imines; Indoles; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Peptides; Propanolamines; Pyrroles; Rats; Scorpion Venoms

1996
Cyclic Adenosine Monophosphate-Mediated Enhancement of Vascular Endothelial Growth Factor Released by Differentiated Human Monocytic Cells: The Role of Protein Kinase A.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2015, Volume: 24, Issue:6

    Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Albuterol; Atenolol; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Ethanolamines; Humans; Isoproterenol; Lipopolysaccharides; Macrophages; Procaterol; Pyrroles; Vascular Endothelial Growth Factor A

2015